FIELD: organic chemistry, steroids, medicine.
SUBSTANCE: invention describes compounds or their salts of the general formula (I): wherein values C are disclosed in the invention description. These compounds can be used in preparing medicinal agents used in treatment of acute disorders in portal and hepatic venous circulation.
EFFECT: valuable medicinal properties of compounds.
4 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
STEROID COMPOUND, PHARMACEUTICAL COMPOSITIONS | 2000 |
|
RU2240325C2 |
TREATMENT OF INTRAHEPATIC CHOLESTASIS AND RELATED LIVER DISEASES | 2016 |
|
RU2743405C2 |
STEROID COMPOUND FOR USE IN TREATMENT OF HEPATIC ENCEPHALOPATHY | 2015 |
|
RU2684616C2 |
METHOD AND DEVICE FOR HEPATIC HEMODYNAMICS ESTIMATION | 2007 |
|
RU2372022C2 |
METHOD FOR TREATMENT OF LIVER DISEASE | 2004 |
|
RU2286773C2 |
COMPLEX PREPARATION WITH HEPATOPROTECTIVE ACTIVITY FOR CATTLE | 2020 |
|
RU2742414C1 |
RESPIRATORY SYSTEM DISEASES TREATMENT | 2013 |
|
RU2693382C2 |
PYRAZOLPYRAMIDINON DERIVATIVE-CONTAINING MEDICINE FOR LIVER DISEASES TREATMENT AND PREVENTION | 2005 |
|
RU2369392C2 |
METHOD FOR TREATING STEATOHEPATITIS | 2003 |
|
RU2248793C1 |
DRUG FOR GASTROINTESTINAL TRACT AND HEPATOBILIARY SYSTEM DISEASES TREATMENT AND PREVENTING RECRUDESCENCES | 2017 |
|
RU2651711C1 |
Authors
Dates
2007-05-27—Published
2003-05-09—Filed